ArticleEuropean journal of clinical pharmacology2018

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.

P Frisk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.